cordycepin has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, C; Ding, X; Dou, M; Han, F; Li, Y; Tian, P; Wang, Y; Xu, C; Xue, W; Zheng, J | 1 |
| Gu, L; Johno, H; Kato, H; Katoh, R; Kitamura, M; Nakajima, S; Takahashi, S | 1 |
2 other study(ies) available for cordycepin and Kidney Diseases
| Article | Year |
|---|---|
Cordycepin protects renal ischemia/reperfusion injury through regulating inflammation, apoptosis, and oxidative stress.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Deoxyadenosines; Humans; Inflammation; Kidney Diseases; Oxidative Stress; Protective Agents; Rats; Reperfusion Injury | 2020 |
Blockade of Smad signaling by 3'-deoxyadenosine: a mechanism for its anti-fibrotic potential.
Topics: Animals; Bone Morphogenetic Protein 4; Cell Line; Deoxyadenosines; Down-Regulation; Drug Evaluation, Preclinical; Eukaryotic Initiation Factor-2; Kidney Diseases; Mice; Mice, Inbred C57BL; Nucleoside Transport Proteins; Rats; Receptors, Purinergic P1; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2013 |